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Background
The CD4 depletion in the chronic phase of HIV infection
is mostly due to the loss of uninfected cells. We recently
showed that the expression of NKp44L, a cellular ligand of
an activating NK receptor was exclusively expressed on
non-infected CD4 cells from HIV-infected patients.
NKp44L is specially induced by the highly conserved 3S
motif of the HIV-1 gp41 envelope protein. In this study
we sought to determine whether the loss of uninfected
bystander CD4 cells could be prevented by an anti-3S vac-
cine.
Methods
Ten cynomolgus macaques were primed/boosted in IFA
with 3S-KLH or free KLH, as control. Sixteen weeks after
the last immunization, all animals were challenged IV
with the SHIV162P3. Peripheral and lymphoid lym-
phocyte samples were periodically tested.
Results
We discovered that 1) During HIV infection, uninfected
CD4 cells exclusively express NKp44L; 2) In a macaque
model of SHIV162P3 infection, a 3S-KLH immunization
significantly decreases NKp44L expression on CD4 cells,
NK cells cytotoxicity and apoptosis, when compared to
infected control group immunized with free KLH. Inter-
estingly, the CD4 cells level of immunized animals
remains stable, while it decreased in the control group.
Conclusion
These results emphasize the deleterious role of NK cells on
the depletion of uninfected bystander CD4 cells. They
also present new opportunities for HIV vaccine strategies,
which should subsequently inhibits and/or delay the dis-
ease evolution to AIDS.
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